2016
Long-term survival in AIDS-related primary central nervous system lymphoma
Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro-Oncology 2016, 19: 99-108. PMID: 27576871, PMCID: PMC5193026, DOI: 10.1093/neuonc/now155.Peer-Reviewed Original ResearchConceptsCombination antiretroviral therapyWhole brain radiotherapyPrimary central nervous system lymphomaCentral nervous system lymphomaAR-PCNSLNervous system lymphomaHD-MTXLong-term survivalMulticenter analysisSystem lymphomaAdvent of cARTLong-term disease-free survivalLonger progression-free survivalSan Francisco General HospitalHigh-dose methotrexateDisease-free survivalProgression-free survivalOptimal therapeutic approachTherapy-related factorsFirst-line interventionPost-cART eraLong-term toxicityAntiretroviral therapyBrain radiotherapyFavorable survival
2012
Primary Central Nervous System Lymphomas
Graber J, Omuro A. Primary Central Nervous System Lymphomas. 2012, 125-133. DOI: 10.1002/9781118321478.ch12.Peer-Reviewed Original ResearchPrimary CNS lymphomaHigh-dose methotrexate-based chemotherapyPrimary central nervous system lymphomaCentral nervous system lymphomaMethotrexate-based chemotherapyNervous system lymphomaNon-Hodgkin lymphomaLong-term survivalCNS lymphomaOptimal regimenImmunosuppressed patientsSystem lymphomaAppropriate therapyDisease relapseEarly suspicionDiagnostic accuracyLymphomaInappropriate interventionsPatientsImmunocompetentRegimenChemotherapyRelapseRadiotherapyNeurotoxicity